Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause
ContinenceAim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade +3 more
doaj +1 more source
Early and long-term rehabilitation after the remodeling laser therapy for GSM
Клинический разбор в общей медицинеEpidemiological data of the recent years further suggest progressive aging of the world’s population. Today, given high life expectancy and the average age of menopause, a woman will be postmenopausal for at least 40% of her entire life.
Mekan R. Orazov +2 more
doaj +1 more source
Genitourinary Syndrome of Menopause: A Systematic Review [PDF]
Genitourinary syndrome is the most common health problem experienced by postmenopausal women. Its pathogenesis is correlated with decreased estrogen levels, which results in thinner vaginal epithelium with a reduced proportion of superficial cells.
Danan ER +17 more
europepmc +3 more sources
Laser Therapy for Genitourinary Syndrome of Menopause (GSM): A Stratified Meta-Analysis of Histological, Clinical, and Safety Outcomes [PDF]
Background: Genitourinary syndrome of menopause (GSM) is a prevalent and chronic condition that diminishes quality of life. Vaginal laser therapy is a non-hormonal treatment, but its efficacy and safety require rigorous synthesis.
Dafnil Akhir Putra +3 more
core +2 more sources
Lubricants application in vulvovaginal atrophy [PDF]
РМЖ. Мать и дитя, 2018 Lubricants application in vulvovaginal atrophy Yu.E. Dobrokhotova, S.A. Khlynova Pirogov Russian National Research Medical University, Moscow, Russian Federation Interim periods as well as the postmenopausal period are extremely important in ...
Yu.E. Dobrokhotova, S.A. Khlynova
doaj
Genitourinary syndrome of menopause: Common problem, effective treatments
Cleveland Clinic Journal of Medicine, 2018 After menopause, about half of all women experience genital, sexual, and urinary symptoms associated with decreases in estrogen, termed genitourinary syndrome of menopause. First-line therapies are nonhormonal vaginal lubricants and moisturizers. For persistent symptoms, prescription estrogen in cream and ring formulations is effective.
Nancy A, Phillips, Gloria A, Bachmann
openaire +2 more sources
Genitourinary syndrome of menopause exploring the history, updates and treatment [PDF]
The biological factors and physiological functions fundamental to the female anatomy delineate the complexity of reproductive phenomenon in this population.
Elfaki, Sara H.
core +2 more sources
Assessing vaginal wall thickness by transvaginal ultrasound in breast cancer survivors: A pilot study [PDF]
Aim: There is need for a straightforward objective measure to evaluate vaginal wall changes related to hypoestrogenism. The aim of this pilot study was to evaluate a transvaginal ultrasound procedure for the quantification of vaginal wall thickness in ...
Anglès Acedo, Sònia +7 more
core +1 more source
Modern therapies for pelvic floor dysfunction in women due to surgical menopause
ГинекологияAim. To compare the effectiveness of the kGoal vaginal trainer combined with the intimate non-hormonal phytocomplex with hyaluronic acid, Estrogial, for the non-surgical treatment of the early stages of pelvic prolapse in women with surgical menopause.
Tatiana Y. Pestrikova +5 more
doaj +1 more source
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies [PDF]
Many breast cancer survivors (BCS) suffer the consequences of antineoplastic treatments that induce a hypoestrogenic state, leading to chronic climacteric symptoms such as genitourinary syndrome of menopause (GSM), arousing significant alteration in ...
Anglès Acedo, Sònia +4 more
core +1 more source